483 Biovex Mar 2017

483 Biovex Mar 2017

Michele Forster FDA, Mihaly Ligmond FDA$119.00 - Available Now

FDA investigators audited the Biovex - Woburn, MA, United States facility and issued inspectional observations (via FDA 483) on 16 Mar 2017.

Product details

  • Category: Biologics
  • Inspection end: 16 Mar 2017
  • Location: Woburn, United States
  • FEI: 3006702185
Add To Cart